Nancy K. Pryer, PhD

Ambagon Therapeutics, California, United States

Nancy K. Pryer, Ph.D. is Chief Scientific Officer at Ambagon Therapeutics, an early stage
company discovering and developing small molecule stabilizers of protein-protein
interactions as novel oncology medicines. Prior to that she held executive
positions at Nurix Therapeutics and Day One Bio, led Translational Sciences at
Biomarin, and led scientific teams at Onyx, SUGEN and Novartis Institutes for
Biomedical Research. She received her Ph.D from the University of North Carolina and conducted postdoctoral research at the University of California, Berkeley

Disclosure information not submitted.

Presentation(s):

• Induced Proximity Beyond Degradation

  Monday, February 5, 2024
  3:00 PM – 5:00 PM EST

• Discovery of small molecule molecular glues stabilizing disease-driving proteins to the 14-3-3 adaptor proteins for novel cancer therapeutics

  Monday, February 5, 2024
  3:00 PM – 3:30 PM EST